Searchable abstracts of presentations at key conferences on calcified tissues

ba0003pp86 | Bone development/growth and fracture repair | ECTS2014

Circulating myostatin in type 2 diabetes subjects: relationship with bone metabolism and fractures

Reyes-Garcia Rebeca , Garcia-Martin Antonia , Garcia-Fontana Beatriz , Morales-Santana Sonia , Rozas-Moreno Pedro , Munoz-Torres Manuel

Introduction: Myostatin (growth differentiation factor 8, GDF-8) has an important role in the regulation of muscle mass, and mice lacking the myostatin gene show a generalized increase in bone density and strength. Type 2 diabetes subjects have an increased risk of fragility fractures despite of higher bone mass. Taking into account the myostatin influence in bone strength a better understanding of myostatin actions in type 2 diabetes is of interest.Obje...

ba0003pp372 | Other diseases of bone and mineral metabolism | ECTS2014

Comparative effect of Denosumab vs Teriparatide on bone and energy metabolism

Rubio Veronica Avila , Rodriguez Cristina Novo , Fontana Beatriz Garcia , Martin Antonia Garcia , Garcia Rebeca Reyes , Santana Sonia Morales , Torres Manuel Munoz

Recent studies have demonstrated the role of osteocalcin in energy metabolism regulation having a connection between this and bone metabolism. According to this, anti-osteoporotic drugs may exert different effects on energy metabolism. Thereby, our aim is to evaluate the effects of antiresorptive (Denosumab) and osteoanabolic (Teriparatide) drugs that reduce or increase respectively osteocalcin levels, on energy and bone metabolism by assessing of undercarboxilated osteocalcin...